Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

Share Price is delayed by 15 minutes
Get Live Data
215.00    -47.50 (-18.10%)
Bid:
210.00
Ask:
220.00
Spread: 10.00 (4.762%)
Market Cap: £64.66m
MPAC Live PriceLast checked at - London Stock Exchange

Intraday Mpac Group Plc Share Chart

Awards under Deferred Share Plan

3 May 2019 13:19

RNS Number : 0679Y
Mpac Group PLC
03 May 2019
 

3 May 2019

 

Mpac Group plc

("Mpac" or the "Company")

Awards under Deferred Share Plan

 

Mpac Group plc announces that on 1 May 2019 its Executive Directors were granted the following share awards as nil-cost options over ordinary shares of 25p each in the Company under the Company's Deferred Share Plan:

 

Director Position Number of Options Granted

Dr A Steels Chief Executive 35,409

Mr W C Wilkins Group Finance Director 33,407

 

Further details relating to the operation of the Deferred Share Plan can be found within the Company's Annual Report and Accounts which are available on the Company's website.

 

Set out below are the notifications, made in accordance with the requirements of the EU Market Abuse Regulation, in relation to the grant of options.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMR") and persons closely associated with them.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr A Steels - Chief Executive

2

Reason for the notification

a)

Position/status

See 1(a) above - Dr Steels is classified as a PDMR of the Company

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25p each ("Ordinary Shares")

GB0005991111

b)

Nature of the transaction

Conditional award of ordinary shares pursuant to the rules of the Company's Deferred Share Plan.

For the award to vest, Dr Steels must remain in employment for three years from the award date. The rights of the shares are deferred, such that any dividends and other distributions attaching to the shares between the date of the award and the realisation date do not form part of the award.

The stated number of shares will be granted to the director at any time requested by the director from the third anniversary of the date of grant to, normally, the fourth anniversary. In exceptional circumstances and at the Company's discretion, the Company may make a cash payment of a sum equivalent to the value of the shares that would otherwise have been granted. In certain circumstances, for example retirement, the director may exercise a proportion of an award before the third-year anniversary of the conditional grant.

c)

Price(s) and volume(s)

Volume(s): Nil cost options over 35,409 shares

 

Price: £Nil

 

 

d)

Aggregated information

- Volume

 

- Price

 

- Total

N/A

e)

Date of the transaction

1 May 2019

f)

Place of the transaction

Outside a trading volume

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr W C Wilkins - Group Finance Director

2

Reason for the notification

a)

Position/status

See 1(a) above - Mr Wilkins is classified as a PDMR of the Company

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25p each ("Ordinary Shares")

GB0005991111

b)

Nature of the transaction

Conditional award of ordinary shares pursuant to the rules of the Company's Deferred Share Plan.

For the award to vest, Mr Wilkins must remain in employment for three years from the award date. The rights of the shares are deferred, such that any dividends and other distributions attaching to the shares between the date of the award and the realisation date do not form part of the award.

The stated number of shares will be granted to the director at any time requested by the director from the third anniversary of the date of grant to, normally, the fourth anniversary. In exceptional circumstances and at the Company's discretion, the Company may make a cash payment of a sum equivalent to the value of the shares that would otherwise have been granted. In certain circumstances, for example retirement, the director may exercise a proportion of an award before the third-year anniversary of the conditional grant.

c)

Price(s) and volume(s)

Volume(s): Nil cost options over 33,407 shares

 

Price: £Nil

 

 

d)

Aggregated information

- Volume

 

- Price

 

- Total

N/A

e)

Date of the transaction

1 May 2019

f)

Place of the transaction

Outside a trading volume

 

For further information, please contact:

Mpac Group plc Tel: +44 (0) 2476 421100

Duncan Tyler, Company Secretary

 

Panmure Gordon (UK) Limited (Nominated Advisor & Broker) Tel: +44 (0) 20 7886 2500

Dominic Morley

James Stearns

 

Hudson Sandler Tel: +44 (0) 20 7796 4133

Nick Lyon

Nick Moore

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBDGDURBGBGCX
Date   Source Headline
17th Mar 20227:00 amRNSFull Year Results
14th Feb 20224:38 pmRNSNotice of Results
12th Jan 20227:00 amRNSFull Year Trading Update
21st Oct 20215:16 pmRNSDirectorate Appointment
2nd Sep 20217:00 amRNSHalf Year Results
13th Aug 20217:00 amRNSEquity Development Investor Webinar
27th Jul 20217:00 amRNSChange of Registered Office Address
26th Jul 202112:12 pmRNSMpac new contract
8th Jul 20217:00 amRNSTrading Update
5th May 20215:00 pmRNSResult of AGM
1st Apr 20214:30 pmRNSPosting of 2020 Annual Report and Notice of AGM
1st Apr 20214:27 pmRNSDirectors/PDMRs Dealing
30th Mar 20217:00 amRNSFull Year Results
11th Mar 20213:42 pmRNSEquity Development Investor Webinar Update
10th Mar 202112:02 pmRNSNotice of Results Update
1st Mar 20219:32 amRNSEquity Development Investor Webinar
17th Feb 20218:00 amRNSNotice of Results
7th Jan 20217:00 amRNSFull Year Trading Update
6th Oct 20203:56 pmRNSLaunch of new brand positioning and website
16th Sep 20209:51 amRNSDirector/PDMR Dealing
10th Sep 20203:37 pmRNSDirector/PDMR Dealing
9th Sep 20207:00 amRNSAcquisition of Switchback Group, Inc.
3rd Sep 20207:00 amRNSHalf year results
7th Aug 20208:00 amRNSEquity Development Investor Webinar
8th Jul 20204:41 pmRNSSecond Price Monitoring Extn
8th Jul 20204:36 pmRNSPrice Monitoring Extension
8th Jul 20202:08 pmRNSSecond Price Monitoring Extn
8th Jul 20202:01 pmRNSPrice Monitoring Extension
8th Jul 202011:06 amRNSSecond Price Monitoring Extn
8th Jul 202011:01 amRNSPrice Monitoring Extension
8th Jul 20209:06 amRNSSecond Price Monitoring Extn
8th Jul 20209:00 amRNSPrice Monitoring Extension
8th Jul 20207:00 amRNSOperating update and notice of results
6th May 20203:36 pmRNSResult of AGM
6th May 20207:00 amRNSAGM Statement
3rd Apr 20207:00 amRNSPosting of 2019 Annual Report and Notice of AGM
26th Mar 20207:00 amRNSCOVID-19, trading update and AGM
20th Mar 20202:08 pmRNSSecond Price Monitoring Extn
20th Mar 20202:01 pmRNSPrice Monitoring Extension
16th Mar 202011:06 amRNSSecond Price Monitoring Extn
16th Mar 202011:01 amRNSPrice Monitoring Extension
6th Mar 20207:00 amRNSBoard Change
4th Mar 20207:00 amRNSFull year results
3rd Mar 202012:48 pmRNSHolding(s) in Company
4th Feb 202011:35 amRNSNotice of Results
9th Jan 202011:07 amRNSSecond Price Monitoring Extn
9th Jan 202011:01 amRNSPrice Monitoring Extension
8th Jan 20207:00 amRNSFull year trading update
9th Dec 20197:00 amRNSChange of Adviser
5th Sep 20197:00 amRNSHalf-year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.